Translation and Validation of the French mPCOSQ (mPCOSQ-F).
Sponsored by CHU de Reims
About this trial
Last updated 9 months ago
Study ID
PS25052
Status
Recruiting
Type
Observational
Placebo
No
Accepting
18 to 45 Years
Female
Trial Timing
Started a year ago
What is this trial about?
This study is a prospective, observational, bicentric study, evaluating the validity and reliability of a French version of the mPCOSQ questionnaire (mPCOSQ-F), used to assess health-related quality of life (HRQOL) in women with polycystic ovary syndrome.
The first stage of the study consisted in translating the questionnaire from English to French.
Patients agreeing to take part in the study will complete the mPCOSQ-F and the SF-36 (generic HRQOL questionnaire). After 1 to 2 weeks, patients will receive the mPCOSQ-F and complete it again.
What are the participation requirements?
Inclusion Criteria
* Women aged 18 to 45
* Fluent in french
* Having a diagnosis of PCOS according to the international recommendations published in 2023
* Willing to participate in the study
* Affiliated to the french social security system
Exclusion Criteria
* Diagnosis of adrenal hyperplasia, androgen-producing tumor, Cushing's syndrome, or thyroid disorder
* Pregnancy or breast-feeding
* Under legal protection